Therapeutically accessible clinical cardiac states

Journal of the American College of Surgeons

Volumn 191, Issue 4, 2000, Pages 452-463

  Robinson, Thomas N ^a   Morrell, Todd D ^a   Pomerantz, Benjamin J ^a   Heimbach, Julie K ^a   Cairns, Charles B ^a   Harken, Alden H ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; ADENOSINE TRIPHOSPHATASE; CYTOCHROME C; POTASSIUM CHANNEL; PYRUVATE DEHYDROGENASE; UBIQUINONE;

APOPTOSIS; BIOENERGY; ENZYME ACTIVITY; HEART FAILURE; HEART INFARCTION PREVENTION; HEART MITOCHONDRION; HEART MUSCLE; HEART MUSCLE NECROSIS; MEMBRANE PERMEABILITY; MEMBRANE POTENTIAL; METABOLITE; MYOCARDIAL HIBERNATION; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; REVIEW; STUNNED HEART MUSCLE; SURGEON;

EID: 0033814424     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(00)00696-7     Document Type: Article

References (103)

1. Noninvasive, infrared monitoring of cerebral and myocardial oxygen sufficiency and circulatory parameters
2. The role of mitochondria in ischemic heart disease
3. Respiratory control and the integration of heart high-energy phosphate metabolism by mitochondrial creatine kinase
4. Early expression of angiogenesis factors in acute myocardial ischemia and infarction
5. Time course and mechanisms of contractile dysfunction during acute myocardial ischemia
6. Cardiac myocyte apoptosis
7. Apoptosis in myocardial ischemia-reperfusion
8. Intracellular ATP levels determine cell death fate by apoptosis or necrosis
9. The mitochondrial death/life regulator in apoptosis and necrosis
10. Gradual onset of myocardial ischemia results in reduced myocardial infarction. Association with reduced contractile function and metabolic downregulation
11. Adenosine preconditioning of human myocardium is dependent upon the ATP-sensitive K+ channel
12. Cardiac contractile function following repetitive brief ischemia: Effects of nucleoside transport inhibition
13. Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning?
14. Cellular mechanisms of infarct size reduction with ischemic preconditioning. Role of calcium?
15. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium
16. Protonic inhibition of the mitochondrial adenosine 5'-triphosphatase in ischemic cardiac muscle. Reversible binding of the ATPase inhibitor protein to the mitochondrial ATPase during ischemia
17. Mechanisms of ischemic preconditioning in rat myocardium. Roles of adenosine, cellular energy state, and mitochondrial F1F0-ATPase
18. Preconditioning preserves mitochondrial function and glycolytic flux during an early period of reperfusion in perfused rat hearts
19. Ischemic preconditioning preserves creatine phosphate and intracellular pH
20. Repetitive episodes of brief ischaemia (12 min) do not produce a cumulative depletion of high energy phosphate compounds
21. Energy metabolism and contractile function after 15 beats of moderate myocardial ischemia
22. Relation between coronary artery stenosis and myocardial purine metabolism, histology and regional function in humans
23. Ischemic preconditioning slows energy metabolism and delays ultra-structural damage during a sustained ischemic episode
24. Effect of ischemic preconditioning on mitochondrial oxidative phosphorylation and high energy phosphates in rat hearts
25. Rebound recovery of myocardial creatine phosphate with reperfusion after ischemia
26. Adaptation to chronic hypoxia alters cardiac metabolic response to beta stimulation: Novel face of phosphocreatine overshoot phenomenon
27. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina
28. Mechanism of myocardial 'stunning'
29. Therapy for myocardial stunning
30. Prolonged myocardial nucleotide depletion after brief ischemia in the open-chest dog
31. Time course of functional and biochemical recovery of myocardium salvaged by reperfusion
32. Relation between high energy phosphate and lethal injury in myocardial ischemia in the dog
33. Regeneration of myocardial phosphocreatine in pigs despite continued moderate ischemia
34. Role of glycolytic products in damage to ischemic myocardium. Dissociation of adenosine triphosphate levels and recovery of function of reperfused ischemic hearts
35. Prolonged depletion of ATP and of the adenine nucleotide pool due to delayed resynthesis of adenine nucleotides following reversible myocardial ischemic injury in dogs
36. Prolonged derangements of canine myocardial purine metabolism after a brief coronary artery occlusion not associated with anatomic evidence of necrosis
37. Chronic myocardial hibernation in humans. From bedside to bench
38. Myocardial cell death and apoptosis in hibernating myocardium
39. Profound apoptosis-mediated regional myocyte loss and compensatory hypertrophy in pigs with hibernating myocardium
40. Mechanism of impaired myocardial function during progressive coronary stenosis in conscious pigs. Hibernation versus stunning?
41. Oxidative phosphorylation at the fin de siecle
42. Control and kinetic analysis of ischemia-damaged heart mitochondria: Which parts of the oxidative phosphorylation system are affected by ischemia?
43. Mitochondrial complexes I, II, III, IV, and V in myocardial ischemia and autolysis
44. Mitochondrial function in the oxygen depleted and reoxygenated myocardial cell
45. Development of ischemia-induced damage in defined mitochondrial subpopulations
46. Kinetic analysis of changes in activity of heart mitochondrial oxidative phosphorylation system induced by ischemia
47. Postischemic administration of succinate reverses the impairment of oxidative phosphorylation after cardiac ischemia and reperfusion injury
48. Improved myocardial preservation during cold storage using substrate enhancement
49. Reduction of infarct size by systemic amino acid supplementation during reperfusion
50. Oxidative phosphorylation function of two mitochondrial preparations from heart: Effects of ischaemia and cytochrome c
51. Myocardial ischemia decreases oxidative phosphorylation through cytochrome oxidase in subsarcolemmal mitochondria
52. Early alteration of the control of mitochondrial function in myocardial ischemia
53. The effect of cytochrome c on the myocardium during reperfusion
54. Elucidation of a tripartite mechanism underlying the improvement in cardiac tolerance to ischemia by coenzyme Q10 pretreatment
55. Acute administration of liposomal coenzyme Q10 increases myocardial tissue levels and improves tolerance to ischemia reperfusion injury
56. The regulation of the matrix volume of mammalian mitochondria in vivo and in vitro and its role in the control of mitochondrial metabolism
57. The mitochondrial KATP channel as a receptor for potassium channel openers
58. Protective effects of ATP-sensitive potassium-channel openers in experimental myocardial ischemia
59. Ischemic cardioprotection by ATP-sensitive K+ channels involves high-energy phosphate preservation
60. Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection
61. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions
62. Dichloroacetate as metabolic therapy for myocardial ischemia and failure
63. Dichloroacetate stimulation of glucose oxidation improves recovery of ischemic rat hearts
64. Dichloroacetate enhances myocardial functional and metabolic recovery following global ischemia
65. The pharmacology of dichloroacetate
66. Mechanism of activation of pyruvate dehydrogenase by dichloroacetate and other halogenated carboxylic acids
67. Effect of glucose-insulin-potassium infusion on myocardial infarction following experimental coronary artery occlusion
68. Effect of glucose-insulin-potassium infusions on arteriovenous differences of glucose of free fatty acids and on tissue metabolic changes in dogs with developing myocardial infarction
69. Enhanced preservation of acutely ischemic myocardium and improved clinical outcomes using glucose-insulin-potassium (GIK) solutions
70. Proof that glucose-insulin-potassium provides metabolic protection of ischaemic myocardium
71. Myocardial protection during percutaneous transluminal coronary angioplasty: Effects of trimetazidine
72. Infarct size in rabbits: A modified method illustrated by the effects of propranolol and trimetazidine
73. Cardioprotective effect of trimetazidine during coronary artery graft surgery
74. Superoxide dismutase conjugated to polyethylene glycol provides sustained protection against myocardial ischemia/reperfusion injury in canine heart
75. The relationship between oxygen radical generation and impairment of myocardial energy metabolism following postischemic reperfusion
76. Role of oxygen radicals in myocardial reperfusion injury: Experimental and clinical evidence
77. Effect of alpha-lipoic acid and dihydrolipoic acid on ischemia/reperfusion injury of the heart and heart mitochondria
78. Increased myocardial tolerance to ischemia-reperfusion injury by feeding pigs with coenzyme Q10
79. The influence of N-acetylcysteine on cardiac function and rhythm disorders during ischemia and reperfusion
80. Role of energy metabolism in the preconditioned heart - A possible contribution of mitochondria
81. Effect of inhibition of the mitochondrial ATPase on net myocardial ATP in total ischemia
82. A naturally occurring inhibitor of mitochondrial adenosine triphosphatase
83. Amino acid sequence of the protein inhibitor of mitochondrial adenosine triphosphatase
84. Effects of oligomycin and acidosis on rates of ATP depletion in ischemic heart muscle
85. Relationship between oxidative phosphorylation and adenine nucleotide translocase activity of two populations of cardiac mitochondria and mechanical recovery of ischemic hearts following reperfusion
86. Atractyloside-induced myocardial cell injury
87. Control of fatty acid metabolism in ischemic and hypoxic hearts
88. Fatty acid homeostasis in the normoxic and ischemic heart
89. Acyl-CoA inhibition of adenine nucleotide translocation in ischemic myocardium
90. Adenine nucleotide transport during cardiac ischemia
91. Protection of the ischemic dog myocardium with carnitine
92. A proposed mechanism for fatty acid effects on energy metabolism of the heart
93. Effects of carnitine in ischemic and fatty acid supplemented swine hearts
94. Mitochondria and apoptosis
95. Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischaemia/reperfusion injury
96. Protection by Cyclosporin A of ischemia/reperfusion-induced damage in isolated rat hearts
97. The role of mitochondria in the salvage and the injury of the ischemic myocardium
98. Regulation of intracellular free Mg2+ and contraction in single adult mammalian cardiac myocytes
99. Mitochondrial membrane potential in single living adult rat cardiac myocytes exposed to anoxia or metabolic inhibition
100. The relationship between mitochondrial state, ATP hydrolysis, [Mg2+]i and [Ca2+]i studied in isolated rat cardiomyocytes